Sign up to our newsletter today
We've been helping students find the right postgraduate course for over a decade.
This programme gives you a thorough grounding in the scientific principles underlying cancer treatment.
You’ll discover how new treatments are developed, evaluated and implemented. By the end of the course you’ll be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues.
You’ll have a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, including early phase clinical trials.
You’ll also take a three-month dissertation under the supervision of one of our research experts. This may involve setting up a ‘mock’ clinical trial to gain experience of clinical research and drug development in the cancer setting.
Read more about this course
The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.
Applicants should have a minimum 2:1 degree in relevant subject (eg, biology/chemistry/pharmacology/medicine), or degree equivalent qualification from a recognised academic institution or an appropriate professional qualification or experience. A 2:2 degree will be considered with strong supporting evidence.
Fees & funding
Start dates & study options
Queen Mary University of London is a Russell Group university with a focus on world-leading research and open inclusivity. Studying your postgraduate degree with us means that you will work with renowned academics at the forefront of their field and become part of our vibrant London community. Whether you want to further explore your chosen academic subject, advance your career or broaden your employment options, a postgraduate degree from Queen Mary could open up doors for you.Read more
Based on your current searches we recommend the following search filters.
Based on our current search criteria we thought you might be interested in these.